BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1030 related articles for article (PubMed ID: 32784685)

  • 1. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
    Al-Kassmy J; Pedersen J; Kobinger G
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of SARS-CoV-2 vaccine candidates.
    Dong Y; Dai T; Wei Y; Zhang L; Zheng M; Zhou F
    Signal Transduct Target Ther; 2020 Oct; 5(1):237. PubMed ID: 33051445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.
    De León-Rodríguez SG; Hernández-Rico B; Olmo-Vázquez GD; Cruz-Dávalos I; Bonifaz LC
    Bol Med Hosp Infant Mex; 2020; 77(5):252-261. PubMed ID: 33064679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Strategies for vaccine development of COVID-19].
    Yang L; Tian D; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):593-604. PubMed ID: 32347054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons for COVID-19 Immunity from Other Coronavirus Infections.
    Sariol A; Perlman S
    Immunity; 2020 Aug; 53(2):248-263. PubMed ID: 32717182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development.
    Khalaj-Hedayati A
    J Immunol Res; 2020; 2020():7201752. PubMed ID: 32695833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological considerations for COVID-19 vaccine strategies.
    Jeyanathan M; Afkhami S; Smaill F; Miller MS; Lichty BD; Xing Z
    Nat Rev Immunol; 2020 Oct; 20(10):615-632. PubMed ID: 32887954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus vaccine-associated lung immunopathology-what is the significance?
    Bottazzi ME; Strych U; Hotez PJ; Corry DB
    Microbes Infect; 2020 Oct; 22(9):403-404. PubMed ID: 32599077
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses.
    Gupta T; Gupta SK
    Int Immunopharmacol; 2020 Sep; 86():106717. PubMed ID: 32585611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for COVID-19: The current state of play.
    Koirala A; Joo YJ; Khatami A; Chiu C; Britton PN
    Paediatr Respir Rev; 2020 Sep; 35():43-49. PubMed ID: 32653463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2: A New Song Recalls an Old Melody.
    Subbarao K
    Cell Host Microbe; 2020 May; 27(5):692-694. PubMed ID: 32407706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.
    Dai L; Zheng T; Xu K; Han Y; Xu L; Huang E; An Y; Cheng Y; Li S; Liu M; Yang M; Li Y; Cheng H; Yuan Y; Zhang W; Ke C; Wong G; Qi J; Qin C; Yan J; Gao GF
    Cell; 2020 Aug; 182(3):722-733.e11. PubMed ID: 32645327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.
    İnandıklıoğlu N; Akkoc T
    Adv Exp Med Biol; 2020; 1288():5-12. PubMed ID: 32514817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
    Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C
    J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination strategies to combat novel corona virus SARS-CoV-2.
    Pandey SC; Pande V; Sati D; Upreti S; Samant M
    Life Sci; 2020 Sep; 256():117956. PubMed ID: 32535078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development.
    Samrat SK; Tharappel AM; Li Z; Li H
    Virus Res; 2020 Oct; 288():198141. PubMed ID: 32846196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.